Inhibition of Hepatitis B Virus Replication by the Host Zinc Finger Antiviral Protein

PLoS Pathogens

Volumn 9, Issue 7, 2013, Pages

  Mao, Richeng ^a,b   Nie, Hui ^a   Cai, Dawei ^a   Zhang, Jiming ^b   Liu, Hongyan ^b   Yan, Ran ^a   Cuconati, Andrea ^c   Block, Timothy M ^a,c   Guo, Ju Tao ^a   Guo, Haitao ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b FUDAN UNIVERSITY   (China)

^c BARUCH S BLUMBERG INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIVIRUS AGENT; FLUOROURACIL; RECOMBINANT ALPHA2A INTERFERON; TETRACYCLINE; UNCLASSIFIED DRUG; ZINC FINGER ANTIVIRAL PROTEIN;

ANTIVIRAL ACTIVITY; ARTICLE; CELL FRACTIONATION; CLINICAL ARTICLE; CONTROLLED STUDY; DNA HYBRIDIZATION; DOWN REGULATION; GENETIC TRANSFECTION; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOFLUORESCENCE TEST; IMMUNOPRECIPITATION; LIVER BIOPSY; NONHUMAN; NORTHERN BLOTTING; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS INHIBITION; VIRUS REPLICATION; WESTERN BLOTTING;

EID: 84884747041     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1003494     Document Type: Article

References (83)

1. Liang TJ, (2009) Hepatitis B: the virus and disease. Hepatology 49: S13-21.
2. Block TM, Guo H, Guo JT, (2007) Molecular virology of hepatitis B virus for clinicians. Clin Liver Dis 11: 685-vii, 685-706, vii.
3. McMahon BJ, (2005) Epidemiology and natural history of hepatitis B. Semin Liver Dis 25 Suppl 1: 3-8.
4. Dandri M, Locarnini S, (2012) New insight in the pathobiology of hepatitis B virus infection. Gut 61 Suppl 1: i6-17.
5. Kuo A, Gish R, (2012) Chronic hepatitis B infection. Clin Liver Dis 16: 347-369.
6. Seeger C, Mason WS, (2000) Hepatitis B virus biology. Microbiol Mol Biol Rev 64: 51-68.
7. Nassal M, (2008) Hepatitis B viruses: reverse transcription a different way. Virus Res 134: 235-249.
8. Wolf D, Goff SP, (2008) Host restriction factors blocking retroviral replication. Annu Rev Genet 42: 143-163.
9. Kirzinger MW, Stavrinides J, (2012) Host specificity determinants as a genetic continuum. Trends Microbiol 20: 88-93.
10. Nguyen DH, Ludgate L, Hu J, (2008) Hepatitis B virus-cell interactions and pathogenesis. J Cell Physiol 216: 289-294.
11. Hu J, Seeger C, (1996) Hsp90 is required for the activity of a hepatitis B virus reverse transcriptase. Proc Natl Acad Sci U S A 93: 1060-1064.
12. Reese V, Ondracek C, Rushing C, Li L, Oropeza CE, et al. (2011) Multiple nuclear receptors may regulate hepatitis B virus biosynthesis during development. Int J Biochem Cell Biol 43: 230-237.
13. Tang H, Banks KE, Anderson AL, McLachlan A, (2001) Hepatitis B virus transcription and replication. Drug News Perspect 14: 325-334.
14. Wang SH, Yeh SH, Lin WH, Yeh KH, Yuan Q, et al. (2012) Estrogen receptor alpha represses transcription of HBV genes via interaction with hepatocyte nuclear factor 4alpha. Gastroenterology 142: 989-e984, 989-998, e984.
15. Isogawa M, Robek MD, Furuichi Y, Chisari FV, (2005) Toll-like receptor signaling inhibits hepatitis B virus replication in vivo. J Virol 79: 7269-7272.
16. Robek MD, Boyd BS, Chisari FV, (2005) Lambda interferon inhibits hepatitis B and C virus replication. J Virol 79: 3851-3854.
17. Robek MD, Boyd BS, Wieland SF, Chisari FV, (2004) Signal transduction pathways that inhibit hepatitis B virus replication. Proc Natl Acad Sci U S A 101: 1743-1747.
18. Kimura K, Kakimi K, Wieland S, Guidotti LG, Chisari FV, (2002) Interleukin-18 inhibits hepatitis B virus replication in the livers of transgenic mice. J Virol 76: 10702-10707.
19. Puro R, Schneider RJ, (2007) Tumor necrosis factor activates a conserved innate antiviral response to hepatitis B virus that destabilizes nucleocapsids and reduces nuclear viral DNA. J Virol 81: 7351-7362.
20. Hosel M, Quasdorff M, Wiegmann K, Webb D, Zedler U, et al. (2009) Not interferon, but interleukin-6 controls early gene expression in hepatitis B virus infection. Hepatology 50: 1773-1782.
21. Chisari FV, Isogawa M, Wieland SF, (2010) Pathogenesis of hepatitis B virus infection. Pathol Biol (Paris) 58: 258-266.
22. Guidotti LG, Chisari FV, (2006) Immunobiology and pathogenesis of viral hepatitis. Annu Rev Pathol 1: 23-61.
23. Kawai T, Akira S, (2006) Innate immune recognition of viral infection. Nat Immunol 7: 131-137.
24. Sadler AJ, Williams BR, (2008) Interferon-inducible antiviral effectors. Nat Rev Immunol 8: 559-568.
25. Wieland SF, Chisari FV, (2005) Stealth and cunning: hepatitis B and hepatitis C viruses. J Virol 79: 9369-9380.
26. Wang H, Ryu WS, (2010) Hepatitis B virus polymerase blocks pattern recognition receptor signaling via interaction with DDX3: implications for immune evasion. PLoS Pathog 6: e1000986.
27. Lang T, Lo C, Skinner N, Locarnini S, Visvanathan K, et al. (2011) The hepatitis B e antigen (HBeAg) targets and suppresses activation of the toll-like receptor signaling pathway. J Hepatol 55: 762-769.
28. Yu S, Chen J, Wu M, Chen H, Kato N, et al. (2010) Hepatitis B virus polymerase inhibits RIG-I- and Toll-like receptor 3-mediated beta interferon induction in human hepatocytes through interference with interferon regulatory factor 3 activation and dampening of the interaction between TBK1/IKKepsilon and DDX3. J Gen Virol 91: 2080-2090.
29. Kumar M, Jung SY, Hodgson AJ, Madden CR, Qin J, et al. (2011) Hepatitis B virus regulatory HBx protein binds to adaptor protein IPS-1 and inhibits the activation of beta interferon. J Virol 85: 987-995.
30. Scaglione SJ, Lok AS, (2012) Effectiveness of hepatitis B treatment in clinical practice. Gastroenterology 142: 1360-e1361, 1360-1368, e1361.
31. Mao R, Zhang J, Jiang D, Cai D, Levy JM, et al. (2011) Indoleamine 2,3-dioxygenase mediates the antiviral effect of gamma interferon against hepatitis B virus in human hepatocyte-derived cells. J Virol 85: 1048-1057.
32. Uprichard SL, Wieland SF, Althage A, Chisari FV, (2003) Transcriptional and posttranscriptional control of hepatitis B virus gene expression. Proc Natl Acad Sci U S A 100: 1310-1315.
33. Rang A, Gunther S, Will H, (1999) Effect of interferon alpha on hepatitis B virus replication and gene expression in transiently transfected human hepatoma cells. J Hepatol 31: 791-799.
34. Wieland SF, Eustaquio A, Whitten-Bauer C, Boyd B, Chisari FV, (2005) Interferon prevents formation of replication-competent hepatitis B virus RNA-containing nucleocapsids. Proc Natl Acad Sci U S A 102: 9913-9917.
35. Robek MD, Wieland SF, Chisari FV, (2002) Inhibition of hepatitis B virus replication by interferon requires proteasome activity. J Virol 76: 3570-3574.
36. Xu C, Guo H, Pan XB, Mao R, Yu W, et al. (2010) Interferons accelerate decay of replication-competent nucleocapsids of hepatitis B virus. J Virol 84: 9332-9340.
37. Gao G, Guo X, Goff SP, (2002) Inhibition of retroviral RNA production by ZAP, a CCCH-type zinc finger protein. Science 297: 1703-1706.
38. Bick MJ, Carroll JW, Gao G, Goff SP, Rice CM, et al. (2003) Expression of the zinc-finger antiviral protein inhibits alphavirus replication. J Virol 77: 11555-11562.
39. Muller S, Moller P, Bick MJ, Wurr S, Becker S, et al. (2007) Inhibition of filovirus replication by the zinc finger antiviral protein. J Virol 81: 2391-2400.
40. Zhang Y, Burke CW, Ryman KD, Klimstra WB, (2007) Identification and characterization of interferon-induced proteins that inhibit alphavirus replication. J Virol 81: 11246-11255.
41. Kerns JA, Emerman M, Malik HS, (2008) Positive selection and increased antiviral activity associated with the PARP-containing isoform of human zinc-finger antiviral protein. PLoS Genet 4: e21.
42. Zhu Y, Chen G, Lv F, Wang X, Ji X, et al. (2011) Zinc-finger antiviral protein inhibits HIV-1 infection by selectively targeting multiply spliced viral mRNAs for degradation. Proc Natl Acad Sci U S A 108: 15834-15839.
43. Wang X, Tu F, Zhu Y, Gao G, (2012) Zinc-finger antiviral protein inhibits XMRV infection. PLoS One 7: e39159.
44. Guo X, Carroll JW, Macdonald MR, Goff SP, Gao G, (2004) The zinc finger antiviral protein directly binds to specific viral mRNAs through the CCCH zinc finger motifs. J Virol 78: 12781-12787.
45. Guo X, Ma J, Sun J, Gao G, (2007) The zinc-finger antiviral protein recruits the RNA processing exosome to degrade the target mRNA. Proc Natl Acad Sci U S A 104: 151-156.
46. Zhu Y, Gao G, (2008) ZAP-mediated mRNA degradation. RNA Biol 5: 65-67.
47. Xuan Y, Liu L, Shen S, Deng H, Gao G, (2012) Zinc finger antiviral protein inhibits murine gammaherpesvirus 68 m2 expression and regulates viral latency in cultured cells. J Virol 86: 12431-12434.
48. Rothnie HM, Chapdelaine Y, Hohn T, (1994) Pararetroviruses and retroviruses: a comparative review of viral structure and gene expression strategies. Adv Virus Res 44: 1-67.
49. MacDonald MR, Machlin ES, Albin OR, Levy DE, (2007) The zinc finger antiviral protein acts synergistically with an interferon-induced factor for maximal activity against alphaviruses. J Virol 81: 13509-13518.
50. Marcello T, Grakoui A, Barba-Spaeth G, Machlin ES, Kotenko SV, et al. (2006) Interferons alpha and lambda inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics. Gastroenterology 131: 1887-1898.
51. Wang N, Dong Q, Li J, Jangra RK, Fan M, et al. (2010) Viral induction of the zinc finger antiviral protein is IRF3-dependent but NF-kappaB-independent. J Biol Chem 285: 6080-6090.
52. Reiterer G, MacDonald R, Browning JD, Morrow J, Matveev SV, et al. (2005) Zinc deficiency increases plasma lipids and atherosclerotic markers in LDL-receptor-deficient mice. J Nutr 135: 2114-2118.
53. Guo H, Jiang D, Ma D, Chang J, Dougherty AM, et al. (2009) Activation of pattern recognition receptor-mediated innate immunity inhibits the replication of hepatitis B virus in human hepatocyte-derived cells. J Virol 83: 847-858.
54. Abraham TM, Lewellyn EB, Haines KM, Loeb DD, (2008) Characterization of the contribution of spliced RNAs of hepatitis B virus to DNA synthesis in transfected cultures of Huh7 and HepG2 cells. Virology 379: 30-37.
55. Liu L, Chen G, Ji X, Gao G, (2004) ZAP is a CRM1-dependent nucleocytoplasmic shuttling protein. Biochem Biophys Res Commun 321: 517-523.
56. Jeong MS, Kim EJ, Jang SB, (2010) Expression and RNA-binding of human zinc-finger antiviral protein. Biochem Biophys Res Commun 396: 696-702.
57. Chen S, Xu Y, Zhang K, Wang X, Sun J, et al. (2012) Structure of N-terminal domain of ZAP indicates how a zinc-finger protein recognizes complex RNA. Nat Struct Mol Biol 19: 430-435.
58. Lai WS, Kennington EA, Blackshear PJ, (2002) Interactions of CCCH zinc finger proteins with mRNA: non-binding tristetraprolin mutants exert an inhibitory effect on degradation of AU-rich element-containing mRNAs. J Biol Chem 277: 9606-9613.
59. Lai WS, Blackshear PJ, (2001) Interactions of CCCH zinc finger proteins with mRNA: tristetraprolin-mediated AU-rich element-dependent mRNA degradation can occur in the absence of a poly(A) tail. J Biol Chem 276: 23144-23154.
60. Lai WS, Carballo E, Thorn JM, Kennington EA, Blackshear PJ, (2000) Interactions of CCCH zinc finger proteins with mRNA. Binding of tristetraprolin-related zinc finger proteins to Au-rich elements and destabilization of mRNA. J Biol Chem 275: 17827-17837.
61. Karki S, Li MM, Schoggins JW, Tian S, Rice CM, et al. (2012) Multiple interferon stimulated genes synergize with the zinc finger antiviral protein to mediate anti-alphavirus activity. PLoS One 7: e37398.
62. Hayakawa S, Shiratori S, Yamato H, Kameyama T, Kitatsuji C, et al. (2011) ZAPS is a potent stimulator of signaling mediated by the RNA helicase RIG-I during antiviral responses. Nat Immunol 12: 37-44.
63. Chisari FV, (1993) The role of cytotoxic T lymphocytes and inflammatory cytokines in the pathogenesis of acute viral hepatitis. Gastroenterol Jpn 28 Suppl 4: 2-6 discussion 17-19.
64. Wieland S, Thimme R, Purcell RH, Chisari FV, (2004) Genomic analysis of the host response to hepatitis B virus infection. Proc Natl Acad Sci U S A 101: 6669-6674.
65. Wieland SF, Vega RG, Muller R, Evans CF, Hilbush B, et al. (2003) Searching for interferon-induced genes that inhibit hepatitis B virus replication in transgenic mouse hepatocytes. J Virol 77: 1227-1236.
66. Lok AS, Heathcote EJ, Hoofnagle JH, (2001) Management of hepatitis B: 2000-summary of a workshop. Gastroenterology 120: 1828-1853.
67. Zoulim F, Mason WS, (2012) Reasons to consider earlier treatment of chronic HBV infections. Gut 61: 333-336.
68. Kawai T, Takahashi K, Sato S, Coban C, Kumar H, et al. (2005) IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat Immunol 6: 981-988.
69. Seth RB, Sun L, Ea CK, Chen ZJ, (2005) Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell 122: 669-682.
70. Meylan E, Curran J, Hofmann K, Moradpour D, Binder M, et al. (2005) Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437: 1167-1172.
71. Xu LG, Wang YY, Han KJ, Li LY, Zhai Z, et al. (2005) VISA is an adapter protein required for virus-triggered IFN-beta signaling. Mol Cell 19: 727-740.
72. Kawai T, Akira S, (2007) Antiviral signaling through pattern recognition receptors. J Biochem 141: 137-145.
73. Takeuchi O, Akira S, (2008) MDA5/RIG-I and virus recognition. Curr Opin Immunol 20: 17-22.
74. Law LM, Albin OR, Carroll JW, Jones CT, Rice CM, et al. (2010) Identification of a dominant negative inhibitor of human zinc finger antiviral protein reveals a functional endogenous pool and critical homotypic interactions. J Virol 84: 4504-4512.
75. Huang Z, Wang X, Gao G, (2010) Analyses of SELEX-derived ZAP-binding RNA aptamers suggest that the binding specificity is determined by both structure and sequence of the RNA. Protein Cell 1: 752-759.
76. Hu J, Lin L, (2009) RNA-protein interactions in hepadnavirus reverse transcription. Front Biosci 14: 1606-1618.
77. Kim VN, (2005) MicroRNA biogenesis: coordinated cropping and dicing. Nat Rev Mol Cell Biol 6: 376-385.
78. Ye P, Liu S, Zhu Y, Chen G, Gao G, (2010) DEXH-Box protein DHX30 is required for optimal function of the zinc-finger antiviral protein. Protein Cell 1: 956-964.
79. Chen G, Guo X, Lv F, Xu Y, Gao G, (2008) p72 DEAD box RNA helicase is required for optimal function of the zinc-finger antiviral protein. Proc Natl Acad Sci U S A 105: 4352-4357.
80. Guo H, Jiang D, Zhou T, Cuconati A, Block TM, et al. (2007) Characterization of the intracellular deproteinized relaxed circular DNA of hepatitis B virus: an intermediate of covalently closed circular DNA formation. J Virol 81: 12472-12484.
81. Guo H, Zhou T, Jiang D, Cuconati A, Xiao GH, et al. (2007) Regulation of hepatitis B virus replication by the phosphatidylinositol 3-kinase-akt signal transduction pathway. J Virol 81: 10072-10080.
82. Schormann W, Kraft A, Ponsel D, Bruss V, (2006) Hepatitis B virus particle formation in the absence of pregenomic RNA and reverse transcriptase. J Virol 80: 4187-4190.
83. Galibert F, Mandart E, Fitoussi F, Charnay P, (1979) Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E.coli. Nature 281: 646-650.